Purchase Order 75N91020P00409
Award Date 4/14/20
Potential Completion Date 3/31/25
Potential Value $5.9K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $23,598.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Bioview (USA), Inc. for a service contract to provide the Bioview Automated Scanner. The contract has a period of performance through July 14, 2025. Bioview is a for-profit medical imaging and diagnostic equipment provider that specializes in automated cell analysis systems. This contract supports NCI's medical research initiatives by...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $21,632 purchase order to Bioview (Usa), Inc., doing business as Bioview, to provide automated scanner services. The contract has a period of performance from July 25, 2023 through June 24, 2024. Under this firm fixed price award, Bioview will deliver its Bioview Automated Scanner to support the NIH NCI's research and diagnostic efforts. The place of performance will be Bioview's...
- <p>The National Cancer Institute awarded a purchase order to Bioview (Usa), Inc. for service on the RiedLab's BioView automated scanner valued at $21,633.21, with an award date of March 2, 2016. Performance will take place in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of January 31, 2017.</p>
- Bioview (Usa), Inc. has been awarded a firm fixed price purchase order by the National Institutes of Health's National Cancer Institute for services supporting medical research efforts. With a potential value of $24,000, this sole source contract has no set aside designation and calls for Bioview to provide unspecified services at the agency's facility in Bethesda, Maryland through February 2027. As a laboratory equipment developer specializing in automated cell diagnostic systems, Bioview...
- <p>The National Cancer Institute issued a purchase order to Bioview (Usa), Inc. for $23,598.00 on April 3, 2019, with an ultimate completion date of April 2, 2020. The order is firm fixed price with no set-aside designation. Performance occurs in Bethesda, Maryland. The order procures medical imaging and diagnostic equipment, specifically automated cell analysis systems and related services for research support. No originating solicitation number is identified in the source.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,034 purchase order to Bioview (Usa), Inc., doing business as Bioview, to provide services in Bethesda, Maryland from August 2023 through February 2024. As a firm fixed price contract, Bioview will deliver unspecified services to support the NIH NCI's mission to conduct and coordinate research, training, health information dissemination, and other programs with respect to the...
- The National Cancer Institute awarded a purchase order to Bioview (Usa), Inc. for maintenance services on a BioView Duet Automated Scanner, valued at $23,598.00, with an award date of August 1, 2026. The order carries a Total Small Business set-aside. Performance occurs at Bethesda, Maryland. Services include annual preventative maintenance, on-site repairs, replacement of worn components, software updates, and technical support via online and telephone for mission-critical equipment...
- This firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Biovision Technologies, Inc., a small business. The $104,850 contract is for the provision of six diode laser lines and a laser merge system to support the NCI's Center for Cancer Research, Laboratory of Cellular and Molecular Biology. This specialized equipment will be integrated with the government's existing CSU-22 confocal system to enhance its...
- <p>The National Cancer Institute awarded a purchase order to Biovision Technologies, Inc., a small business, on February 6, 2020, for a high-resolution camera for an existing microscope, with a ceiling value of $12,468.00. Work is performed in Exton, Pennsylvania, with an ultimate completion date of February 5, 2021. The order carries firm fixed pricing.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,875 purchase order to Biocare Medical LLC of Rockville, Maryland. Under the terms of the firm fixed price contract, Biocare Medical will provide service for the IntelliPath FLX biocare system to the agency through July 2024. The contract supports the National Cancer Institute's research efforts by maintaining laboratory instrumentation at its Rockville location. No subcontractors...